AffiliationDivision of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool
MetadataShow full item record
AbstractRas proteins are important signalling hubs situated near the top of networks controlling cell proliferation, differentiation and survival. Three almost identical isoforms, HRAS, KRAS and NRAS, are ubiquitously expressed yet have differing biological and oncogenic properties. In order to help understand the relative biological contributions of each isoform we have optimised a quantitative proteomics method for accurately measuring Ras isoform protein copy number per cell. The use of isotopic protein standards together with selected reaction monitoring for diagnostic peptides is sensitive, robust and suitable for application to sub-milligram quantities of lysates. We find that in a panel of isogenic SW48 colorectal cancer cells, endogenous Ras proteins are highly abundant with ≥260,000 total Ras protein copies per cell and the rank order of isoform abundance is KRAS>NRAS≥HRAS. A subset of oncogenic KRAS mutants exhibit increased total cellular Ras abundance and altered the ratio of mutant versus wild type KRAS protein. These data and methodology are significant because Ras protein copy number is required to parameterise models of signalling networks and informs interpretation of isoform-specific Ras functional data.
CitationAbsolute Quantification of Endogenous Ras Isoform Abundance. 2015, 10 (11):e0142674 PLoS ONE
- A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation.
- Authors: Bentley C, Jurinka SS, Kljavin NM, Vartanian S, Ramani SR, Gonzalez LC, Yu K, Modrusan Z, Du P, Bourgon R, Neve RM, Stokoe D
- Issue date: 2013 Jun 1
- Non-Redundant and Overlapping Oncogenic Readouts of Non-Canonical and Novel Colorectal Cancer KRAS and NRAS Mutants.
- Authors: Alcantara KMM, Malapit JRP, Yu RTD, Garrido JAMG, Rigor JPT, Angeles AKJ, Cutiongco-de la Paz EM, Garcia RL
- Issue date: 2019 Dec 3
- Isoform-specific Ras signaling is growth factor dependent.
- Authors: Hood FE, Klinger B, Newlaczyl AU, Sieber A, Dorel M, Oliver SP, Coulson JM, Blüthgen N, Prior IA
- Issue date: 2019 Apr 15
- Reduced HRAS G12V-Driven Tumorigenesis of Cell Lines Expressing KRAS C118S.
- Authors: Huang L, Counter CM
- Issue date: 2015
- Comparison of liver oncogenic potential among human RAS isoforms.
- Authors: Chung SI, Moon H, Ju HL, Kim DY, Cho KJ, Ribback S, Dombrowski F, Calvisi DF, Ro SW
- Issue date: 2016 Feb 9